nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—sarcoma—uterine cancer	0.223	1	CtDrD
Mitoxantrone—Topoisomerase Inhibitors—Etoposide—uterine cancer	0.215	0.43	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Epirubicin—uterine cancer	0.148	0.296	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Doxorubicin—uterine cancer	0.137	0.274	CiPCiCtD
Mitoxantrone—CYP1B1—Progesterone—uterine cancer	0.0273	0.14	CbGbCtD
Mitoxantrone—TOP2A—Epirubicin—uterine cancer	0.0201	0.103	CbGbCtD
Mitoxantrone—ABCC1—Progesterone—uterine cancer	0.0194	0.0996	CbGbCtD
Mitoxantrone—TOP2A—Etoposide—uterine cancer	0.0157	0.0804	CbGbCtD
Mitoxantrone—ABCC1—Dactinomycin—uterine cancer	0.0154	0.079	CbGbCtD
Mitoxantrone—ABCC1—Epirubicin—uterine cancer	0.0112	0.0572	CbGbCtD
Mitoxantrone—TOP2A—Doxorubicin—uterine cancer	0.0107	0.0548	CbGbCtD
Mitoxantrone—ABCG2—Dactinomycin—uterine cancer	0.0103	0.0528	CbGbCtD
Mitoxantrone—ABCC1—Etoposide—uterine cancer	0.00869	0.0446	CbGbCtD
Mitoxantrone—CYP1B1—Doxorubicin—uterine cancer	0.00834	0.0428	CbGbCtD
Mitoxantrone—ABCG2—Carboplatin—uterine cancer	0.00693	0.0355	CbGbCtD
Mitoxantrone—ABCC1—Doxorubicin—uterine cancer	0.00593	0.0304	CbGbCtD
Mitoxantrone—ABCG2—Etoposide—uterine cancer	0.00582	0.0298	CbGbCtD
Mitoxantrone—ABCB1—Progesterone—uterine cancer	0.00469	0.024	CbGbCtD
Mitoxantrone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00424	0.0217	CbGbCtD
Mitoxantrone—CYP2E1—Etoposide—uterine cancer	0.00415	0.0213	CbGbCtD
Mitoxantrone—ABCG2—Doxorubicin—uterine cancer	0.00397	0.0203	CbGbCtD
Mitoxantrone—ABCB1—Dactinomycin—uterine cancer	0.00372	0.0191	CbGbCtD
Mitoxantrone—CYP3A4—Progesterone—uterine cancer	0.00281	0.0144	CbGbCtD
Mitoxantrone—ABCB1—Etoposide—uterine cancer	0.0021	0.0108	CbGbCtD
Mitoxantrone—ABCB1—Doxorubicin—uterine cancer	0.00143	0.00733	CbGbCtD
Mitoxantrone—CYP3A4—Etoposide—uterine cancer	0.00126	0.00644	CbGbCtD
Mitoxantrone—BTK—myometrium—uterine cancer	0.000858	0.0408	CbGeAlD
Mitoxantrone—CYP3A4—Doxorubicin—uterine cancer	0.000857	0.00439	CbGbCtD
Mitoxantrone—SLC47A2—renal system—uterine cancer	0.000828	0.0394	CbGeAlD
Mitoxantrone—PIM1—myometrium—uterine cancer	0.000743	0.0354	CbGeAlD
Mitoxantrone—BTK—decidua—uterine cancer	0.000636	0.0303	CbGeAlD
Mitoxantrone—SLC47A2—vagina—uterine cancer	0.0006	0.0285	CbGeAlD
Mitoxantrone—BTK—mammalian vulva—uterine cancer	0.000584	0.0278	CbGeAlD
Mitoxantrone—PIM1—uterine cervix—uterine cancer	0.000578	0.0275	CbGeAlD
Mitoxantrone—PIM1—decidua—uterine cancer	0.000551	0.0262	CbGeAlD
Mitoxantrone—PIM1—renal system—uterine cancer	0.000541	0.0257	CbGeAlD
Mitoxantrone—PIM1—endometrium—uterine cancer	0.000523	0.0249	CbGeAlD
Mitoxantrone—PIM1—mammalian vulva—uterine cancer	0.000506	0.0241	CbGeAlD
Mitoxantrone—PIM1—uterus—uterine cancer	0.000482	0.0229	CbGeAlD
Mitoxantrone—BTK—female gonad—uterine cancer	0.000455	0.0217	CbGeAlD
Mitoxantrone—BTK—vagina—uterine cancer	0.000452	0.0215	CbGeAlD
Mitoxantrone—TOP2A—myometrium—uterine cancer	0.000436	0.0207	CbGeAlD
Mitoxantrone—PIM1—female reproductive system—uterine cancer	0.000433	0.0206	CbGeAlD
Mitoxantrone—SLC47A1—myometrium—uterine cancer	0.000398	0.0189	CbGeAlD
Mitoxantrone—PIM1—female gonad—uterine cancer	0.000394	0.0188	CbGeAlD
Mitoxantrone—PIM1—vagina—uterine cancer	0.000392	0.0186	CbGeAlD
Mitoxantrone—TOP2A—uterine cervix—uterine cancer	0.000339	0.0161	CbGeAlD
Mitoxantrone—TOP2A—decidua—uterine cancer	0.000323	0.0154	CbGeAlD
Mitoxantrone—SLC47A1—uterine cervix—uterine cancer	0.00031	0.0147	CbGeAlD
Mitoxantrone—TOP2A—endometrium—uterine cancer	0.000307	0.0146	CbGeAlD
Mitoxantrone—TOP2A—mammalian vulva—uterine cancer	0.000297	0.0141	CbGeAlD
Mitoxantrone—SLC47A1—decidua—uterine cancer	0.000295	0.014	CbGeAlD
Mitoxantrone—BTK—lymph node—uterine cancer	0.000293	0.0139	CbGeAlD
Mitoxantrone—SLC47A1—renal system—uterine cancer	0.00029	0.0138	CbGeAlD
Mitoxantrone—TOP2A—uterus—uterine cancer	0.000283	0.0135	CbGeAlD
Mitoxantrone—SLC47A1—endometrium—uterine cancer	0.00028	0.0133	CbGeAlD
Mitoxantrone—SLC47A1—mammalian vulva—uterine cancer	0.000271	0.0129	CbGeAlD
Mitoxantrone—ABCC1—myometrium—uterine cancer	0.000263	0.0125	CbGeAlD
Mitoxantrone—SLC47A1—uterus—uterine cancer	0.000258	0.0123	CbGeAlD
Mitoxantrone—PIM1—lymph node—uterine cancer	0.000253	0.0121	CbGeAlD
Mitoxantrone—SLC47A1—female reproductive system—uterine cancer	0.000232	0.011	CbGeAlD
Mitoxantrone—TOP2A—female gonad—uterine cancer	0.000231	0.011	CbGeAlD
Mitoxantrone—TOP2A—vagina—uterine cancer	0.00023	0.0109	CbGeAlD
Mitoxantrone—CYP1B1—smooth muscle tissue—uterine cancer	0.000221	0.0105	CbGeAlD
Mitoxantrone—ABCG2—myometrium—uterine cancer	0.000217	0.0103	CbGeAlD
Mitoxantrone—CYP1B1—decidua—uterine cancer	0.000216	0.0103	CbGeAlD
Mitoxantrone—CYP1B1—renal system—uterine cancer	0.000212	0.0101	CbGeAlD
Mitoxantrone—SLC47A1—female gonad—uterine cancer	0.000211	0.0101	CbGeAlD
Mitoxantrone—SLC47A1—vagina—uterine cancer	0.00021	0.00999	CbGeAlD
Mitoxantrone—ABCC1—uterine cervix—uterine cancer	0.000204	0.00972	CbGeAlD
Mitoxantrone—ABCC1—decidua—uterine cancer	0.000195	0.00926	CbGeAlD
Mitoxantrone—CYP1B1—uterus—uterine cancer	0.000189	0.00901	CbGeAlD
Mitoxantrone—ABCC1—endometrium—uterine cancer	0.000185	0.00879	CbGeAlD
Mitoxantrone—ABCC1—mammalian vulva—uterine cancer	0.000179	0.0085	CbGeAlD
Mitoxantrone—ABCC1—uterus—uterine cancer	0.00017	0.0081	CbGeAlD
Mitoxantrone—CYP1B1—female reproductive system—uterine cancer	0.00017	0.0081	CbGeAlD
Mitoxantrone—ABCG2—uterine cervix—uterine cancer	0.000169	0.00805	CbGeAlD
Mitoxantrone—ABCG2—decidua—uterine cancer	0.000161	0.00767	CbGeAlD
Mitoxantrone—CYP1B1—female gonad—uterine cancer	0.000155	0.00737	CbGeAlD
Mitoxantrone—ABCG2—endometrium—uterine cancer	0.000153	0.00728	CbGeAlD
Mitoxantrone—TOP2A—lymph node—uterine cancer	0.000149	0.00708	CbGeAlD
Mitoxantrone—ABCG2—mammalian vulva—uterine cancer	0.000148	0.00704	CbGeAlD
Mitoxantrone—ABCG2—uterus—uterine cancer	0.000141	0.00671	CbGeAlD
Mitoxantrone—ABCC1—female gonad—uterine cancer	0.000139	0.00663	CbGeAlD
Mitoxantrone—ABCC1—vagina—uterine cancer	0.000138	0.00659	CbGeAlD
Mitoxantrone—CYP2E1—renal system—uterine cancer	0.000137	0.00652	CbGeAlD
Mitoxantrone—SLC47A1—lymph node—uterine cancer	0.000136	0.00646	CbGeAlD
Mitoxantrone—TOP2A—Podofilox—Etoposide—uterine cancer	0.00013	0.136	CbGdCrCtD
Mitoxantrone—TOP2A—Teniposide—Etoposide—uterine cancer	0.00013	0.136	CbGdCrCtD
Mitoxantrone—ABCG2—female gonad—uterine cancer	0.000115	0.00549	CbGeAlD
Mitoxantrone—ABCG2—vagina—uterine cancer	0.000115	0.00545	CbGeAlD
Mitoxantrone—CYP3A4—renal system—uterine cancer	0.00011	0.00524	CbGeAlD
Mitoxantrone—CYP2E1—female reproductive system—uterine cancer	0.00011	0.00522	CbGeAlD
Mitoxantrone—ABCB1—myometrium—uterine cancer	0.000107	0.0051	CbGeAlD
Mitoxantrone—TOP2A—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.000106	0.111	CbGdCrCtD
Mitoxantrone—CYP1B1—lymph node—uterine cancer	9.95e-05	0.00474	CbGeAlD
Mitoxantrone—TOP2A—Methyltestosterone—Progesterone—uterine cancer	9.27e-05	0.0965	CbGdCrCtD
Mitoxantrone—ABCC1—lymph node—uterine cancer	8.95e-05	0.00426	CbGeAlD
Mitoxantrone—CYP3A4—female reproductive system—uterine cancer	8.83e-05	0.0042	CbGeAlD
Mitoxantrone—ABCB1—epithelium—uterine cancer	8.41e-05	0.004	CbGeAlD
Mitoxantrone—ABCB1—uterine cervix—uterine cancer	8.34e-05	0.00397	CbGeAlD
Mitoxantrone—ABCB1—decidua—uterine cancer	7.95e-05	0.00378	CbGeAlD
Mitoxantrone—ABCB1—renal system—uterine cancer	7.8e-05	0.00371	CbGeAlD
Mitoxantrone—ABCB1—endometrium—uterine cancer	7.54e-05	0.00359	CbGeAlD
Mitoxantrone—ABCG2—lymph node—uterine cancer	7.41e-05	0.00353	CbGeAlD
Mitoxantrone—ABCB1—mammalian vulva—uterine cancer	7.3e-05	0.00347	CbGeAlD
Mitoxantrone—ABCB1—uterus—uterine cancer	6.95e-05	0.00331	CbGeAlD
Mitoxantrone—TOP2A—Daunorubicin—Epirubicin—uterine cancer	6.8e-05	0.0708	CbGdCrCtD
Mitoxantrone—TOP2A—Doxorubicin—Epirubicin—uterine cancer	6.8e-05	0.0708	CbGdCrCtD
Mitoxantrone—TOP2A—Idarubicin—Epirubicin—uterine cancer	6.8e-05	0.0708	CbGdCrCtD
Mitoxantrone—TOP2A—Idarubicin—Doxorubicin—uterine cancer	6.29e-05	0.0655	CbGdCrCtD
Mitoxantrone—TOP2A—Epirubicin—Doxorubicin—uterine cancer	6.29e-05	0.0655	CbGdCrCtD
Mitoxantrone—TOP2A—Daunorubicin—Doxorubicin—uterine cancer	6.29e-05	0.0655	CbGdCrCtD
Mitoxantrone—ABCB1—female reproductive system—uterine cancer	6.25e-05	0.00297	CbGeAlD
Mitoxantrone—TOP2A—Norethindrone—Progesterone—uterine cancer	6.04e-05	0.0629	CbGdCrCtD
Mitoxantrone—ABCB1—female gonad—uterine cancer	5.69e-05	0.00271	CbGeAlD
Mitoxantrone—ABCB1—vagina—uterine cancer	5.65e-05	0.00269	CbGeAlD
Mitoxantrone—Thrombocytopenia—Dactinomycin—uterine cancer	5.51e-05	0.00124	CcSEcCtD
Mitoxantrone—Diarrhoea—Progesterone—uterine cancer	5.44e-05	0.00123	CcSEcCtD
Mitoxantrone—Phlebitis—Epirubicin—uterine cancer	5.39e-05	0.00122	CcSEcCtD
Mitoxantrone—Anorexia—Dactinomycin—uterine cancer	5.36e-05	0.00121	CcSEcCtD
Mitoxantrone—Ecchymosis—Doxorubicin—uterine cancer	5.35e-05	0.00121	CcSEcCtD
Mitoxantrone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	5.31e-05	0.0012	CcSEcCtD
Mitoxantrone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	5.17e-05	0.00117	CcSEcCtD
Mitoxantrone—Chills—Etoposide—uterine cancer	5.14e-05	0.00116	CcSEcCtD
Mitoxantrone—Sepsis—Doxorubicin—uterine cancer	5.13e-05	0.00116	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	5.12e-05	0.00116	CcSEcCtD
Mitoxantrone—Cardiac failure congestive—Epirubicin—uterine cancer	5.12e-05	0.00115	CcSEcCtD
Mitoxantrone—Alopecia—Etoposide—uterine cancer	5.06e-05	0.00114	CcSEcCtD
Mitoxantrone—Vomiting—Progesterone—uterine cancer	5.06e-05	0.00114	CcSEcCtD
Mitoxantrone—Renal failure acute—Epirubicin—uterine cancer	5.03e-05	0.00113	CcSEcCtD
Mitoxantrone—Rash—Progesterone—uterine cancer	5.02e-05	0.00113	CcSEcCtD
Mitoxantrone—Dermatitis—Progesterone—uterine cancer	5.01e-05	0.00113	CcSEcCtD
Mitoxantrone—Phlebitis—Doxorubicin—uterine cancer	4.99e-05	0.00112	CcSEcCtD
Mitoxantrone—Headache—Progesterone—uterine cancer	4.98e-05	0.00112	CcSEcCtD
Mitoxantrone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	4.93e-05	0.00111	CcSEcCtD
Mitoxantrone—Decreased appetite—Dactinomycin—uterine cancer	4.89e-05	0.0011	CcSEcCtD
Mitoxantrone—Dysgeusia—Etoposide—uterine cancer	4.88e-05	0.0011	CcSEcCtD
Mitoxantrone—Fatigue—Dactinomycin—uterine cancer	4.85e-05	0.00109	CcSEcCtD
Mitoxantrone—Back pain—Etoposide—uterine cancer	4.82e-05	0.00109	CcSEcCtD
Mitoxantrone—Pain—Dactinomycin—uterine cancer	4.81e-05	0.00109	CcSEcCtD
Mitoxantrone—TOP2A—Levonorgestrel—Progesterone—uterine cancer	4.81e-05	0.05	CbGdCrCtD
Mitoxantrone—Anaphylactoid reaction—Epirubicin—uterine cancer	4.8e-05	0.00108	CcSEcCtD
Mitoxantrone—Cardiac failure—Epirubicin—uterine cancer	4.76e-05	0.00107	CcSEcCtD
Mitoxantrone—Cardiac failure congestive—Doxorubicin—uterine cancer	4.74e-05	0.00107	CcSEcCtD
Mitoxantrone—Nausea—Progesterone—uterine cancer	4.73e-05	0.00107	CcSEcCtD
Mitoxantrone—Hyponatraemia—Epirubicin—uterine cancer	4.66e-05	0.00105	CcSEcCtD
Mitoxantrone—Renal failure acute—Doxorubicin—uterine cancer	4.65e-05	0.00105	CcSEcCtD
Mitoxantrone—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	4.64e-05	0.00105	CcSEcCtD
Mitoxantrone—Feeling abnormal—Dactinomycin—uterine cancer	4.63e-05	0.00105	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Etoposide—uterine cancer	4.63e-05	0.00104	CcSEcCtD
Mitoxantrone—Anaemia—Etoposide—uterine cancer	4.61e-05	0.00104	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Dactinomycin—uterine cancer	4.6e-05	0.00104	CcSEcCtD
Mitoxantrone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	4.58e-05	0.00103	CcSEcCtD
Mitoxantrone—Rash—Medroxyprogesterone Acetate—uterine cancer	4.55e-05	0.00103	CcSEcCtD
Mitoxantrone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	4.54e-05	0.00102	CcSEcCtD
Mitoxantrone—Headache—Medroxyprogesterone Acetate—uterine cancer	4.52e-05	0.00102	CcSEcCtD
Mitoxantrone—Malaise—Etoposide—uterine cancer	4.5e-05	0.00101	CcSEcCtD
Mitoxantrone—Leukopenia—Etoposide—uterine cancer	4.46e-05	0.00101	CcSEcCtD
Mitoxantrone—Abdominal pain—Dactinomycin—uterine cancer	4.45e-05	0.001	CcSEcCtD
Mitoxantrone—Body temperature increased—Dactinomycin—uterine cancer	4.45e-05	0.001	CcSEcCtD
Mitoxantrone—Anaphylactoid reaction—Doxorubicin—uterine cancer	4.44e-05	0.001	CcSEcCtD
Mitoxantrone—Cardiac failure—Doxorubicin—uterine cancer	4.4e-05	0.000993	CcSEcCtD
Mitoxantrone—Cough—Etoposide—uterine cancer	4.35e-05	0.000982	CcSEcCtD
Mitoxantrone—Blood creatinine increased—Epirubicin—uterine cancer	4.35e-05	0.000981	CcSEcCtD
Mitoxantrone—Convulsion—Etoposide—uterine cancer	4.32e-05	0.000975	CcSEcCtD
Mitoxantrone—Dehydration—Epirubicin—uterine cancer	4.32e-05	0.000974	CcSEcCtD
Mitoxantrone—Hyponatraemia—Doxorubicin—uterine cancer	4.31e-05	0.000973	CcSEcCtD
Mitoxantrone—Hypertension—Etoposide—uterine cancer	4.31e-05	0.000971	CcSEcCtD
Mitoxantrone—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	4.29e-05	0.000969	CcSEcCtD
Mitoxantrone—Nausea—Medroxyprogesterone Acetate—uterine cancer	4.28e-05	0.000966	CcSEcCtD
Mitoxantrone—Chest pain—Etoposide—uterine cancer	4.25e-05	0.000958	CcSEcCtD
Mitoxantrone—Abdominal pain upper—Epirubicin—uterine cancer	4.24e-05	0.000957	CcSEcCtD
Mitoxantrone—Hypokalaemia—Epirubicin—uterine cancer	4.22e-05	0.000953	CcSEcCtD
Mitoxantrone—Discomfort—Etoposide—uterine cancer	4.19e-05	0.000946	CcSEcCtD
Mitoxantrone—Aspartate aminotransferase increased—Epirubicin—uterine cancer	4.18e-05	0.000943	CcSEcCtD
Mitoxantrone—Hypersensitivity—Dactinomycin—uterine cancer	4.14e-05	0.000935	CcSEcCtD
Mitoxantrone—Confusional state—Etoposide—uterine cancer	4.1e-05	0.000926	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Epirubicin—uterine cancer	4.09e-05	0.000924	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Etoposide—uterine cancer	4.07e-05	0.000918	CcSEcCtD
Mitoxantrone—Infection—Etoposide—uterine cancer	4.04e-05	0.000912	CcSEcCtD
Mitoxantrone—Asthenia—Dactinomycin—uterine cancer	4.03e-05	0.00091	CcSEcCtD
Mitoxantrone—Blood creatinine increased—Doxorubicin—uterine cancer	4.02e-05	0.000908	CcSEcCtD
Mitoxantrone—Dehydration—Doxorubicin—uterine cancer	3.99e-05	0.000901	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Etoposide—uterine cancer	3.98e-05	0.000899	CcSEcCtD
Mitoxantrone—Tachycardia—Etoposide—uterine cancer	3.97e-05	0.000896	CcSEcCtD
Mitoxantrone—Skin disorder—Etoposide—uterine cancer	3.95e-05	0.000892	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Etoposide—uterine cancer	3.93e-05	0.000888	CcSEcCtD
Mitoxantrone—Abdominal pain upper—Doxorubicin—uterine cancer	3.92e-05	0.000885	CcSEcCtD
Mitoxantrone—Hypokalaemia—Doxorubicin—uterine cancer	3.91e-05	0.000882	CcSEcCtD
Mitoxantrone—Anorexia—Etoposide—uterine cancer	3.88e-05	0.000875	CcSEcCtD
Mitoxantrone—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	3.87e-05	0.000873	CcSEcCtD
Mitoxantrone—Diarrhoea—Dactinomycin—uterine cancer	3.85e-05	0.000868	CcSEcCtD
Mitoxantrone—Pancytopenia—Epirubicin—uterine cancer	3.81e-05	0.00086	CcSEcCtD
Mitoxantrone—Hypotension—Etoposide—uterine cancer	3.8e-05	0.000858	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Doxorubicin—uterine cancer	3.79e-05	0.000855	CcSEcCtD
Mitoxantrone—Neutropenia—Epirubicin—uterine cancer	3.75e-05	0.000846	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Epirubicin—uterine cancer	3.73e-05	0.000841	CcSEcCtD
Mitoxantrone—ABCB1—lymph node—uterine cancer	3.66e-05	0.00174	CbGeAlD
Mitoxantrone—Paraesthesia—Etoposide—uterine cancer	3.65e-05	0.000825	CcSEcCtD
Mitoxantrone—Weight increased—Epirubicin—uterine cancer	3.65e-05	0.000824	CcSEcCtD
Mitoxantrone—Weight decreased—Epirubicin—uterine cancer	3.63e-05	0.000819	CcSEcCtD
Mitoxantrone—Dyspnoea—Etoposide—uterine cancer	3.63e-05	0.000819	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Epirubicin—uterine cancer	3.62e-05	0.000817	CcSEcCtD
Mitoxantrone—Somnolence—Etoposide—uterine cancer	3.62e-05	0.000816	CcSEcCtD
Mitoxantrone—Pneumonia—Epirubicin—uterine cancer	3.6e-05	0.000812	CcSEcCtD
Mitoxantrone—Drowsiness—Epirubicin—uterine cancer	3.58e-05	0.000807	CcSEcCtD
Mitoxantrone—Vomiting—Dactinomycin—uterine cancer	3.58e-05	0.000807	CcSEcCtD
Mitoxantrone—Rash—Dactinomycin—uterine cancer	3.55e-05	0.0008	CcSEcCtD
Mitoxantrone—Decreased appetite—Etoposide—uterine cancer	3.54e-05	0.000798	CcSEcCtD
Mitoxantrone—Pancytopenia—Doxorubicin—uterine cancer	3.53e-05	0.000795	CcSEcCtD
Mitoxantrone—Renal failure—Epirubicin—uterine cancer	3.52e-05	0.000793	CcSEcCtD
Mitoxantrone—Fatigue—Etoposide—uterine cancer	3.51e-05	0.000792	CcSEcCtD
Mitoxantrone—Stomatitis—Epirubicin—uterine cancer	3.49e-05	0.000787	CcSEcCtD
Mitoxantrone—Jaundice—Epirubicin—uterine cancer	3.49e-05	0.000787	CcSEcCtD
Mitoxantrone—Constipation—Etoposide—uterine cancer	3.48e-05	0.000785	CcSEcCtD
Mitoxantrone—Pain—Etoposide—uterine cancer	3.48e-05	0.000785	CcSEcCtD
Mitoxantrone—Conjunctivitis—Epirubicin—uterine cancer	3.48e-05	0.000785	CcSEcCtD
Mitoxantrone—Urinary tract infection—Epirubicin—uterine cancer	3.48e-05	0.000785	CcSEcCtD
Mitoxantrone—Neutropenia—Doxorubicin—uterine cancer	3.47e-05	0.000783	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Doxorubicin—uterine cancer	3.45e-05	0.000778	CcSEcCtD
Mitoxantrone—Sweating—Epirubicin—uterine cancer	3.43e-05	0.000774	CcSEcCtD
Mitoxantrone—Haematuria—Epirubicin—uterine cancer	3.41e-05	0.00077	CcSEcCtD
Mitoxantrone—Weight increased—Doxorubicin—uterine cancer	3.38e-05	0.000762	CcSEcCtD
Mitoxantrone—Weight decreased—Doxorubicin—uterine cancer	3.36e-05	0.000758	CcSEcCtD
Mitoxantrone—Sinusitis—Epirubicin—uterine cancer	3.36e-05	0.000757	CcSEcCtD
Mitoxantrone—Feeling abnormal—Etoposide—uterine cancer	3.35e-05	0.000757	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Doxorubicin—uterine cancer	3.35e-05	0.000756	CcSEcCtD
Mitoxantrone—Nausea—Dactinomycin—uterine cancer	3.34e-05	0.000754	CcSEcCtD
Mitoxantrone—Agranulocytosis—Epirubicin—uterine cancer	3.34e-05	0.000753	CcSEcCtD
Mitoxantrone—Pneumonia—Doxorubicin—uterine cancer	3.33e-05	0.000751	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Etoposide—uterine cancer	3.33e-05	0.000751	CcSEcCtD
Mitoxantrone—Drowsiness—Doxorubicin—uterine cancer	3.31e-05	0.000747	CcSEcCtD
Mitoxantrone—Bradycardia—Epirubicin—uterine cancer	3.27e-05	0.000738	CcSEcCtD
Mitoxantrone—Renal failure—Doxorubicin—uterine cancer	3.25e-05	0.000734	CcSEcCtD
Mitoxantrone—Urticaria—Etoposide—uterine cancer	3.23e-05	0.00073	CcSEcCtD
Mitoxantrone—Haemoglobin—Epirubicin—uterine cancer	3.23e-05	0.000728	CcSEcCtD
Mitoxantrone—Stomatitis—Doxorubicin—uterine cancer	3.23e-05	0.000728	CcSEcCtD
Mitoxantrone—Jaundice—Doxorubicin—uterine cancer	3.23e-05	0.000728	CcSEcCtD
Mitoxantrone—Rhinitis—Epirubicin—uterine cancer	3.22e-05	0.000726	CcSEcCtD
Mitoxantrone—Abdominal pain—Etoposide—uterine cancer	3.22e-05	0.000726	CcSEcCtD
Mitoxantrone—Body temperature increased—Etoposide—uterine cancer	3.22e-05	0.000726	CcSEcCtD
Mitoxantrone—Conjunctivitis—Doxorubicin—uterine cancer	3.22e-05	0.000726	CcSEcCtD
Mitoxantrone—Urinary tract infection—Doxorubicin—uterine cancer	3.22e-05	0.000726	CcSEcCtD
Mitoxantrone—Haemorrhage—Epirubicin—uterine cancer	3.21e-05	0.000725	CcSEcCtD
Mitoxantrone—Hepatitis—Epirubicin—uterine cancer	3.21e-05	0.000725	CcSEcCtD
Mitoxantrone—Pharyngitis—Epirubicin—uterine cancer	3.19e-05	0.000719	CcSEcCtD
Mitoxantrone—Sweating—Doxorubicin—uterine cancer	3.17e-05	0.000716	CcSEcCtD
Mitoxantrone—Haematuria—Doxorubicin—uterine cancer	3.16e-05	0.000712	CcSEcCtD
Mitoxantrone—Sinusitis—Doxorubicin—uterine cancer	3.11e-05	0.000701	CcSEcCtD
Mitoxantrone—Agranulocytosis—Doxorubicin—uterine cancer	3.09e-05	0.000697	CcSEcCtD
Mitoxantrone—Bradycardia—Doxorubicin—uterine cancer	3.02e-05	0.000683	CcSEcCtD
Mitoxantrone—Hypersensitivity—Etoposide—uterine cancer	3e-05	0.000677	CcSEcCtD
Mitoxantrone—Haemoglobin—Doxorubicin—uterine cancer	2.99e-05	0.000674	CcSEcCtD
Mitoxantrone—Rhinitis—Doxorubicin—uterine cancer	2.98e-05	0.000672	CcSEcCtD
Mitoxantrone—Haemorrhage—Doxorubicin—uterine cancer	2.97e-05	0.00067	CcSEcCtD
Mitoxantrone—Hepatitis—Doxorubicin—uterine cancer	2.97e-05	0.00067	CcSEcCtD
Mitoxantrone—Pharyngitis—Doxorubicin—uterine cancer	2.95e-05	0.000665	CcSEcCtD
Mitoxantrone—Asthenia—Etoposide—uterine cancer	2.92e-05	0.000659	CcSEcCtD
Mitoxantrone—Chills—Epirubicin—uterine cancer	2.88e-05	0.00065	CcSEcCtD
Mitoxantrone—Arrhythmia—Epirubicin—uterine cancer	2.87e-05	0.000647	CcSEcCtD
Mitoxantrone—Alopecia—Epirubicin—uterine cancer	2.84e-05	0.00064	CcSEcCtD
Mitoxantrone—Erythema—Epirubicin—uterine cancer	2.8e-05	0.000631	CcSEcCtD
Mitoxantrone—Diarrhoea—Etoposide—uterine cancer	2.78e-05	0.000628	CcSEcCtD
Mitoxantrone—Dysgeusia—Epirubicin—uterine cancer	2.74e-05	0.000618	CcSEcCtD
Mitoxantrone—Back pain—Epirubicin—uterine cancer	2.7e-05	0.00061	CcSEcCtD
Mitoxantrone—Chills—Doxorubicin—uterine cancer	2.67e-05	0.000602	CcSEcCtD
Mitoxantrone—Arrhythmia—Doxorubicin—uterine cancer	2.65e-05	0.000599	CcSEcCtD
Mitoxantrone—Vision blurred—Epirubicin—uterine cancer	2.63e-05	0.000594	CcSEcCtD
Mitoxantrone—Alopecia—Doxorubicin—uterine cancer	2.63e-05	0.000592	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Epirubicin—uterine cancer	2.59e-05	0.000585	CcSEcCtD
Mitoxantrone—Vomiting—Etoposide—uterine cancer	2.59e-05	0.000584	CcSEcCtD
Mitoxantrone—Erythema—Doxorubicin—uterine cancer	2.59e-05	0.000584	CcSEcCtD
Mitoxantrone—Anaemia—Epirubicin—uterine cancer	2.58e-05	0.000583	CcSEcCtD
Mitoxantrone—Rash—Etoposide—uterine cancer	2.57e-05	0.000579	CcSEcCtD
Mitoxantrone—Dermatitis—Etoposide—uterine cancer	2.56e-05	0.000578	CcSEcCtD
Mitoxantrone—Headache—Etoposide—uterine cancer	2.55e-05	0.000575	CcSEcCtD
Mitoxantrone—Dysgeusia—Doxorubicin—uterine cancer	2.53e-05	0.000572	CcSEcCtD
Mitoxantrone—Malaise—Epirubicin—uterine cancer	2.52e-05	0.000569	CcSEcCtD
Mitoxantrone—Leukopenia—Epirubicin—uterine cancer	2.5e-05	0.000565	CcSEcCtD
Mitoxantrone—Back pain—Doxorubicin—uterine cancer	2.5e-05	0.000565	CcSEcCtD
Mitoxantrone—Cough—Epirubicin—uterine cancer	2.44e-05	0.00055	CcSEcCtD
Mitoxantrone—Vision blurred—Doxorubicin—uterine cancer	2.44e-05	0.00055	CcSEcCtD
Mitoxantrone—Convulsion—Epirubicin—uterine cancer	2.42e-05	0.000546	CcSEcCtD
Mitoxantrone—Nausea—Etoposide—uterine cancer	2.42e-05	0.000545	CcSEcCtD
Mitoxantrone—Hypertension—Epirubicin—uterine cancer	2.41e-05	0.000545	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Doxorubicin—uterine cancer	2.4e-05	0.000541	CcSEcCtD
Mitoxantrone—Anaemia—Doxorubicin—uterine cancer	2.39e-05	0.000539	CcSEcCtD
Mitoxantrone—Chest pain—Epirubicin—uterine cancer	2.38e-05	0.000537	CcSEcCtD
Mitoxantrone—Arthralgia—Epirubicin—uterine cancer	2.38e-05	0.000537	CcSEcCtD
Mitoxantrone—Myalgia—Epirubicin—uterine cancer	2.38e-05	0.000537	CcSEcCtD
Mitoxantrone—Anxiety—Epirubicin—uterine cancer	2.37e-05	0.000535	CcSEcCtD
Mitoxantrone—Discomfort—Epirubicin—uterine cancer	2.35e-05	0.000531	CcSEcCtD
Mitoxantrone—Malaise—Doxorubicin—uterine cancer	2.33e-05	0.000526	CcSEcCtD
Mitoxantrone—Leukopenia—Doxorubicin—uterine cancer	2.32e-05	0.000522	CcSEcCtD
Mitoxantrone—Confusional state—Epirubicin—uterine cancer	2.3e-05	0.000519	CcSEcCtD
Mitoxantrone—Oedema—Epirubicin—uterine cancer	2.28e-05	0.000515	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Epirubicin—uterine cancer	2.28e-05	0.000515	CcSEcCtD
Mitoxantrone—Infection—Epirubicin—uterine cancer	2.27e-05	0.000511	CcSEcCtD
Mitoxantrone—Cough—Doxorubicin—uterine cancer	2.26e-05	0.000509	CcSEcCtD
Mitoxantrone—Shock—Epirubicin—uterine cancer	2.24e-05	0.000506	CcSEcCtD
Mitoxantrone—Convulsion—Doxorubicin—uterine cancer	2.24e-05	0.000506	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Epirubicin—uterine cancer	2.23e-05	0.000504	CcSEcCtD
Mitoxantrone—Hypertension—Doxorubicin—uterine cancer	2.23e-05	0.000504	CcSEcCtD
Mitoxantrone—Tachycardia—Epirubicin—uterine cancer	2.23e-05	0.000502	CcSEcCtD
Mitoxantrone—Skin disorder—Epirubicin—uterine cancer	2.22e-05	0.0005	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Epirubicin—uterine cancer	2.21e-05	0.000498	CcSEcCtD
Mitoxantrone—Myalgia—Doxorubicin—uterine cancer	2.2e-05	0.000497	CcSEcCtD
Mitoxantrone—Arthralgia—Doxorubicin—uterine cancer	2.2e-05	0.000497	CcSEcCtD
Mitoxantrone—Chest pain—Doxorubicin—uterine cancer	2.2e-05	0.000497	CcSEcCtD
Mitoxantrone—Anxiety—Doxorubicin—uterine cancer	2.19e-05	0.000495	CcSEcCtD
Mitoxantrone—Discomfort—Doxorubicin—uterine cancer	2.18e-05	0.000491	CcSEcCtD
Mitoxantrone—Anorexia—Epirubicin—uterine cancer	2.17e-05	0.000491	CcSEcCtD
Mitoxantrone—Hypotension—Epirubicin—uterine cancer	2.13e-05	0.000481	CcSEcCtD
Mitoxantrone—Confusional state—Doxorubicin—uterine cancer	2.13e-05	0.00048	CcSEcCtD
Mitoxantrone—Oedema—Doxorubicin—uterine cancer	2.11e-05	0.000476	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Doxorubicin—uterine cancer	2.11e-05	0.000476	CcSEcCtD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—KRAS—uterine cancer	2.11e-05	0.00137	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—KRAS—uterine cancer	2.11e-05	0.00137	CbGpPWpGaD
Mitoxantrone—Infection—Doxorubicin—uterine cancer	2.1e-05	0.000473	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Epirubicin—uterine cancer	2.08e-05	0.000469	CcSEcCtD
Mitoxantrone—Shock—Doxorubicin—uterine cancer	2.08e-05	0.000469	CcSEcCtD
Mitoxantrone—TOP2A—Cell Cycle—YWHAE—uterine cancer	2.07e-05	0.00134	CbGpPWpGaD
Mitoxantrone—Thrombocytopenia—Doxorubicin—uterine cancer	2.07e-05	0.000466	CcSEcCtD
Mitoxantrone—Tachycardia—Doxorubicin—uterine cancer	2.06e-05	0.000465	CcSEcCtD
Mitoxantrone—BTK—DAP12 signaling—PIK3CA—uterine cancer	2.06e-05	0.00133	CbGpPWpGaD
Mitoxantrone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	2.06e-05	0.00133	CbGpPWpGaD
Mitoxantrone—Skin disorder—Doxorubicin—uterine cancer	2.05e-05	0.000463	CcSEcCtD
Mitoxantrone—Paraesthesia—Epirubicin—uterine cancer	2.05e-05	0.000462	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Doxorubicin—uterine cancer	2.04e-05	0.00046	CcSEcCtD
Mitoxantrone—Dyspnoea—Epirubicin—uterine cancer	2.03e-05	0.000459	CcSEcCtD
Mitoxantrone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	2.03e-05	0.00132	CbGpPWpGaD
Mitoxantrone—Somnolence—Epirubicin—uterine cancer	2.03e-05	0.000458	CcSEcCtD
Mitoxantrone—Anorexia—Doxorubicin—uterine cancer	2.01e-05	0.000454	CcSEcCtD
Mitoxantrone—Dyspepsia—Epirubicin—uterine cancer	2.01e-05	0.000453	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—FGFR2—uterine cancer	1.99e-05	0.00129	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	1.98e-05	0.00129	CbGpPWpGaD
Mitoxantrone—Decreased appetite—Epirubicin—uterine cancer	1.98e-05	0.000447	CcSEcCtD
Mitoxantrone—Hypotension—Doxorubicin—uterine cancer	1.97e-05	0.000445	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.97e-05	0.00128	CbGpPWpGaD
Mitoxantrone—Fatigue—Epirubicin—uterine cancer	1.97e-05	0.000444	CcSEcCtD
Mitoxantrone—Constipation—Epirubicin—uterine cancer	1.95e-05	0.00044	CcSEcCtD
Mitoxantrone—Pain—Epirubicin—uterine cancer	1.95e-05	0.00044	CcSEcCtD
Mitoxantrone—BTK—B Cell Activation—KRAS—uterine cancer	1.95e-05	0.00126	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—PIK3CA—uterine cancer	1.93e-05	0.00125	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—PIK3CA—uterine cancer	1.93e-05	0.00125	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.93e-05	0.00125	CbGpPWpGaD
Mitoxantrone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	1.92e-05	0.000434	CcSEcCtD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—AKT1—uterine cancer	1.92e-05	0.00124	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—FGFR2—uterine cancer	1.91e-05	0.00124	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—CYP19A1—uterine cancer	1.91e-05	0.00124	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—HRAS—uterine cancer	1.9e-05	0.00123	CbGpPWpGaD
Mitoxantrone—Paraesthesia—Doxorubicin—uterine cancer	1.9e-05	0.000428	CcSEcCtD
Mitoxantrone—BTK—Immune System—IRF1—uterine cancer	1.9e-05	0.00123	CbGpPWpGaD
Mitoxantrone—Dyspnoea—Doxorubicin—uterine cancer	1.88e-05	0.000425	CcSEcCtD
Mitoxantrone—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	1.88e-05	0.00122	CbGpPWpGaD
Mitoxantrone—Feeling abnormal—Epirubicin—uterine cancer	1.88e-05	0.000424	CcSEcCtD
Mitoxantrone—Somnolence—Doxorubicin—uterine cancer	1.88e-05	0.000423	CcSEcCtD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.87e-05	0.00121	CbGpPWpGaD
Mitoxantrone—Gastrointestinal pain—Epirubicin—uterine cancer	1.87e-05	0.000421	CcSEcCtD
Mitoxantrone—Dyspepsia—Doxorubicin—uterine cancer	1.86e-05	0.000419	CcSEcCtD
Mitoxantrone—Decreased appetite—Doxorubicin—uterine cancer	1.84e-05	0.000414	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.82e-05	0.00118	CbGpPWpGaD
Mitoxantrone—Fatigue—Doxorubicin—uterine cancer	1.82e-05	0.000411	CcSEcCtD
Mitoxantrone—Urticaria—Epirubicin—uterine cancer	1.81e-05	0.000409	CcSEcCtD
Mitoxantrone—Pain—Doxorubicin—uterine cancer	1.81e-05	0.000407	CcSEcCtD
Mitoxantrone—Constipation—Doxorubicin—uterine cancer	1.81e-05	0.000407	CcSEcCtD
Mitoxantrone—Abdominal pain—Epirubicin—uterine cancer	1.8e-05	0.000407	CcSEcCtD
Mitoxantrone—Body temperature increased—Epirubicin—uterine cancer	1.8e-05	0.000407	CcSEcCtD
Mitoxantrone—BTK—B Cell Activation—PIK3CA—uterine cancer	1.79e-05	0.00116	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—HRAS—uterine cancer	1.79e-05	0.00116	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—HRAS—uterine cancer	1.79e-05	0.00116	CbGpPWpGaD
Mitoxantrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	1.78e-05	0.00116	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDKN2B—uterine cancer	1.74e-05	0.00113	CbGpPWpGaD
Mitoxantrone—Feeling abnormal—Doxorubicin—uterine cancer	1.74e-05	0.000393	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Doxorubicin—uterine cancer	1.73e-05	0.000389	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.72e-05	0.00112	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FBXW7—uterine cancer	1.7e-05	0.0011	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Epirubicin—uterine cancer	1.68e-05	0.000379	CcSEcCtD
Mitoxantrone—BTK—DAP12 signaling—AKT1—uterine cancer	1.68e-05	0.00109	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.68e-05	0.00109	CbGpPWpGaD
Mitoxantrone—Urticaria—Doxorubicin—uterine cancer	1.68e-05	0.000378	CcSEcCtD
Mitoxantrone—Body temperature increased—Doxorubicin—uterine cancer	1.67e-05	0.000377	CcSEcCtD
Mitoxantrone—Abdominal pain—Doxorubicin—uterine cancer	1.67e-05	0.000377	CcSEcCtD
Mitoxantrone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.67e-05	0.00108	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—HRAS—uterine cancer	1.66e-05	0.00107	CbGpPWpGaD
Mitoxantrone—Asthenia—Epirubicin—uterine cancer	1.64e-05	0.000369	CcSEcCtD
Mitoxantrone—ABCC1—Metabolism—SRD5A2—uterine cancer	1.62e-05	0.00105	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NDUFB11—uterine cancer	1.62e-05	0.00105	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—PTEN—uterine cancer	1.61e-05	0.00104	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.6e-05	0.00104	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—AKT1—uterine cancer	1.58e-05	0.00102	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—AKT1—uterine cancer	1.58e-05	0.00102	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.58e-05	0.00102	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	1.57e-05	0.00102	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SRD5A2—uterine cancer	1.57e-05	0.00102	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NDUFB11—uterine cancer	1.57e-05	0.00102	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Epirubicin—uterine cancer	1.56e-05	0.000352	CcSEcCtD
Mitoxantrone—TOP2A—Cell Cycle—CDKN2B—uterine cancer	1.56e-05	0.00101	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Doxorubicin—uterine cancer	1.56e-05	0.000351	CcSEcCtD
Mitoxantrone—TOP2A—Circadian rythm related genes—EP300—uterine cancer	1.54e-05	0.000996	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.52e-05	0.000989	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.52e-05	0.000983	CbGpPWpGaD
Mitoxantrone—Asthenia—Doxorubicin—uterine cancer	1.51e-05	0.000342	CcSEcCtD
Mitoxantrone—ABCC1—Disease—AKR1B10—uterine cancer	1.51e-05	0.000977	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—BIRC5—uterine cancer	1.5e-05	0.000975	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.49e-05	0.000965	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—AKT1—uterine cancer	1.46e-05	0.000948	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	1.46e-05	0.000944	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	1.46e-05	0.000944	CbGpPWpGaD
Mitoxantrone—Vomiting—Epirubicin—uterine cancer	1.45e-05	0.000327	CcSEcCtD
Mitoxantrone—Diarrhoea—Doxorubicin—uterine cancer	1.44e-05	0.000326	CcSEcCtD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.44e-05	0.000934	CbGpPWpGaD
Mitoxantrone—Rash—Epirubicin—uterine cancer	1.44e-05	0.000325	CcSEcCtD
Mitoxantrone—Dermatitis—Epirubicin—uterine cancer	1.44e-05	0.000324	CcSEcCtD
Mitoxantrone—Headache—Epirubicin—uterine cancer	1.43e-05	0.000322	CcSEcCtD
Mitoxantrone—ABCG2—Metabolism—NDUFB11—uterine cancer	1.43e-05	0.000926	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SRD5A2—uterine cancer	1.43e-05	0.000926	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CDH1—uterine cancer	1.42e-05	0.000922	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—SOCS3—uterine cancer	1.39e-05	0.000901	CbGpPWpGaD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.38e-05	0.000894	CbGpPWpGaD
Mitoxantrone—Nausea—Epirubicin—uterine cancer	1.36e-05	0.000306	CcSEcCtD
Mitoxantrone—TOP2A—Cell Cycle—BIRC5—uterine cancer	1.34e-05	0.000871	CbGpPWpGaD
Mitoxantrone—Vomiting—Doxorubicin—uterine cancer	1.34e-05	0.000303	CcSEcCtD
Mitoxantrone—Rash—Doxorubicin—uterine cancer	1.33e-05	0.0003	CcSEcCtD
Mitoxantrone—Dermatitis—Doxorubicin—uterine cancer	1.33e-05	0.0003	CcSEcCtD
Mitoxantrone—Headache—Doxorubicin—uterine cancer	1.32e-05	0.000298	CcSEcCtD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	1.32e-05	0.000857	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.29e-05	0.000835	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	1.28e-05	0.000829	CbGpPWpGaD
Mitoxantrone—Nausea—Doxorubicin—uterine cancer	1.25e-05	0.000283	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—ERBB2—uterine cancer	1.25e-05	0.00081	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—RNF43—uterine cancer	1.25e-05	0.00081	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CXCL8—uterine cancer	1.24e-05	0.000807	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	1.23e-05	0.000799	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	1.2e-05	0.00078	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—ERBB2—uterine cancer	1.2e-05	0.000778	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.19e-05	0.000773	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	1.19e-05	0.00077	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	1.18e-05	0.000768	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.18e-05	0.000768	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKR1B1—uterine cancer	1.17e-05	0.000761	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—STAR—uterine cancer	1.17e-05	0.000761	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	1.17e-05	0.000757	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.16e-05	0.000752	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FGFR2—uterine cancer	1.16e-05	0.000752	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CDKN1B—uterine cancer	1.16e-05	0.00075	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.14e-05	0.000743	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKR1B1—uterine cancer	1.13e-05	0.000736	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—STAR—uterine cancer	1.13e-05	0.000736	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.12e-05	0.000728	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	1.12e-05	0.000727	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CDKN1B—uterine cancer	1.11e-05	0.000721	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—TP53—uterine cancer	1.1e-05	0.000713	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CTNNB1—uterine cancer	1.09e-05	0.000709	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—PTEN—uterine cancer	1.07e-05	0.000691	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—STAR—uterine cancer	1.03e-05	0.00067	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKR1B1—uterine cancer	1.03e-05	0.00067	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKR1C1—uterine cancer	1.03e-05	0.000667	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NDUFB11—uterine cancer	1.03e-05	0.000665	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SRD5A2—uterine cancer	1.03e-05	0.000665	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PTEN—uterine cancer	1.02e-05	0.000663	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—EP300—uterine cancer	1.02e-05	0.000659	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—VEGFA—uterine cancer	1.01e-05	0.000656	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDKN2A—uterine cancer	9.96e-06	0.000646	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	9.67e-06	0.000627	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—NRAS—uterine cancer	9.5e-06	0.000616	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—POLD1—uterine cancer	9.21e-06	0.000597	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—NRAS—uterine cancer	9.13e-06	0.000592	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—POLD1—uterine cancer	8.91e-06	0.000578	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN2A—uterine cancer	8.9e-06	0.000578	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—DCN—uterine cancer	8.9e-06	0.000577	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	8.85e-06	0.000574	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	8.83e-06	0.000572	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDKN1B—uterine cancer	8.82e-06	0.000572	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	8.73e-06	0.000566	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDH1—uterine cancer	8.62e-06	0.000559	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKR1C1—uterine cancer	8.61e-06	0.000559	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKR1C1—uterine cancer	8.33e-06	0.00054	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—KRAS—uterine cancer	8.18e-06	0.000531	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—POLD1—uterine cancer	8.1e-06	0.000525	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKR1C3—uterine cancer	7.92e-06	0.000513	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN1B—uterine cancer	7.89e-06	0.000511	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—KRAS—uterine cancer	7.86e-06	0.000509	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—EP300—uterine cancer	7.74e-06	0.000502	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SRD5A2—uterine cancer	7.72e-06	0.000501	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NDUFB11—uterine cancer	7.72e-06	0.000501	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HMGA1—uterine cancer	7.71e-06	0.0005	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—RRM2—uterine cancer	7.68e-06	0.000498	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKR1C1—uterine cancer	7.58e-06	0.000491	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—PIK3CA—uterine cancer	7.52e-06	0.000487	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—DCN—uterine cancer	7.45e-06	0.000483	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	7.45e-06	0.000483	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—RRM2—uterine cancer	7.42e-06	0.000481	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKR1B1—uterine cancer	7.41e-06	0.000481	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—STAR—uterine cancer	7.41e-06	0.000481	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ERBB2—uterine cancer	7.28e-06	0.000472	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PIK3CA—uterine cancer	7.22e-06	0.000468	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—DCN—uterine cancer	7.21e-06	0.000467	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FBXW7—uterine cancer	7.06e-06	0.000458	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP11A1—uterine cancer	7.02e-06	0.000455	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—HRAS—uterine cancer	6.95e-06	0.000451	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—EP300—uterine cancer	6.92e-06	0.000449	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP11A1—uterine cancer	6.79e-06	0.00044	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—RRM2—uterine cancer	6.75e-06	0.000438	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDKN1B—uterine cancer	6.74e-06	0.000437	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HRAS—uterine cancer	6.68e-06	0.000433	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKR1C3—uterine cancer	6.63e-06	0.00043	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—DCN—uterine cancer	6.56e-06	0.000425	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	6.48e-06	0.00042	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKR1C3—uterine cancer	6.41e-06	0.000416	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CTNNB1—uterine cancer	6.37e-06	0.000413	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PTEN—uterine cancer	6.21e-06	0.000402	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP11A1—uterine cancer	6.18e-06	0.000401	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—AKT1—uterine cancer	6.14e-06	0.000398	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	6e-06	0.000389	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—EP300—uterine cancer	5.92e-06	0.000384	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—AKT1—uterine cancer	5.9e-06	0.000382	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKR1C3—uterine cancer	5.83e-06	0.000378	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—POLD1—uterine cancer	5.82e-06	0.000377	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	5.67e-06	0.000368	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKR1B1—uterine cancer	5.58e-06	0.000362	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—STAR—uterine cancer	5.58e-06	0.000362	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—NRAS—uterine cancer	5.54e-06	0.000359	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN2B—uterine cancer	5.53e-06	0.000359	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	5.52e-06	0.000358	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKR1C1—uterine cancer	5.44e-06	0.000353	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	5.27e-06	0.000342	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—STK11—uterine cancer	5.17e-06	0.000335	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP19A1—uterine cancer	5.17e-06	0.000335	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SMAD3—uterine cancer	5.05e-06	0.000327	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—STK11—uterine cancer	5e-06	0.000324	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP19A1—uterine cancer	5e-06	0.000324	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	4.99e-06	0.000324	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—uterine cancer	4.96e-06	0.000321	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—RRM2—uterine cancer	4.85e-06	0.000315	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.85e-06	0.000314	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGFR2—uterine cancer	4.81e-06	0.000312	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—KRAS—uterine cancer	4.76e-06	0.000309	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NDUFB11—uterine cancer	4.76e-06	0.000309	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SRD5A2—uterine cancer	4.76e-06	0.000309	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—DCN—uterine cancer	4.71e-06	0.000305	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.69e-06	0.000304	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTHFR—uterine cancer	4.63e-06	0.000301	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.62e-06	0.0003	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—STK11—uterine cancer	4.54e-06	0.000295	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP19A1—uterine cancer	4.54e-06	0.000295	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.47e-06	0.00029	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP11A1—uterine cancer	4.44e-06	0.000288	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—POLD1—uterine cancer	4.38e-06	0.000284	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PIK3CA—uterine cancer	4.38e-06	0.000284	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	4.24e-06	0.000275	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKR1C3—uterine cancer	4.19e-06	0.000272	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKR1C1—uterine cancer	4.1e-06	0.000266	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HRAS—uterine cancer	4.05e-06	0.000263	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.9e-06	0.000253	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MTHFR—uterine cancer	3.88e-06	0.000252	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.77e-06	0.000244	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MTHFR—uterine cancer	3.75e-06	0.000243	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—RRM2—uterine cancer	3.65e-06	0.000237	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—AKT1—uterine cancer	3.58e-06	0.000232	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—DCN—uterine cancer	3.55e-06	0.00023	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKR1B1—uterine cancer	3.44e-06	0.000223	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—STAR—uterine cancer	3.44e-06	0.000223	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.42e-06	0.000222	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MTHFR—uterine cancer	3.42e-06	0.000222	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP11A1—uterine cancer	3.34e-06	0.000217	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.31e-06	0.000215	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP19A1—uterine cancer	3.26e-06	0.000212	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—STK11—uterine cancer	3.26e-06	0.000212	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.18e-06	0.000206	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKR1C3—uterine cancer	3.15e-06	0.000205	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERBB2—uterine cancer	3.02e-06	0.000196	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1B—uterine cancer	2.8e-06	0.000182	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—POLD1—uterine cancer	2.7e-06	0.000175	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CTNNB1—uterine cancer	2.65e-06	0.000172	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTEN—uterine cancer	2.58e-06	0.000167	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.52e-06	0.000164	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EP300—uterine cancer	2.46e-06	0.000159	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP19A1—uterine cancer	2.46e-06	0.000159	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—STK11—uterine cancer	2.46e-06	0.000159	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MTHFR—uterine cancer	2.45e-06	0.000159	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NRAS—uterine cancer	2.3e-06	0.000149	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—RRM2—uterine cancer	2.25e-06	0.000146	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—DCN—uterine cancer	2.18e-06	0.000142	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTEN—uterine cancer	2.16e-06	0.00014	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTEN—uterine cancer	2.09e-06	0.000135	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—EP300—uterine cancer	2.06e-06	0.000134	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.06e-06	0.000133	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—EP300—uterine cancer	1.99e-06	0.000129	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KRAS—uterine cancer	1.98e-06	0.000128	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.94e-06	0.000126	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTEN—uterine cancer	1.9e-06	0.000123	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTHFR—uterine cancer	1.85e-06	0.00012	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CA—uterine cancer	1.82e-06	0.000118	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—EP300—uterine cancer	1.81e-06	0.000118	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HRAS—uterine cancer	1.68e-06	0.000109	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CA—uterine cancer	1.52e-06	9.88e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.51e-06	9.82e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—STK11—uterine cancer	1.51e-06	9.82e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT1—uterine cancer	1.49e-06	9.64e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CA—uterine cancer	1.47e-06	9.56e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTEN—uterine cancer	1.36e-06	8.85e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CA—uterine cancer	1.34e-06	8.69e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—EP300—uterine cancer	1.3e-06	8.44e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKT1—uterine cancer	1.24e-06	8.07e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKT1—uterine cancer	1.2e-06	7.81e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTHFR—uterine cancer	1.14e-06	7.38e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKT1—uterine cancer	1.09e-06	7.1e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTEN—uterine cancer	1.03e-06	6.66e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—EP300—uterine cancer	9.8e-07	6.35e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CA—uterine cancer	9.62e-07	6.24e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKT1—uterine cancer	7.86e-07	5.1e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CA—uterine cancer	7.25e-07	4.7e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTEN—uterine cancer	6.33e-07	4.1e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—EP300—uterine cancer	6.04e-07	3.91e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKT1—uterine cancer	5.92e-07	3.84e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CA—uterine cancer	4.46e-07	2.9e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKT1—uterine cancer	3.65e-07	2.37e-05	CbGpPWpGaD
